Particularly, the activation of TGFβ signaling through SMAD4 after doxorubicin treatment (Fig. 5) contributed to YAP‐dependent AXL expression in mesenchymal‐type lung cancer cells (Fig. 6). This evidence concerns the gene TGFB1 and lung cancer.